Stay updated on CAN04 Combined with FOLFIRINOX in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the CAN04 Combined with FOLFIRINOX in Pancreatic Cancer Clinical Trial page.

Latest updates to the CAN04 Combined with FOLFIRINOX in Pancreatic Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2; removed the government funding lapse notice and Revision: v3.4.1.SummaryDifference0.4%

- Check21 days agoChange DetectedThe page now displays a site-wide government funding notice and updates the revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedUI and metadata updates: a Show glossary option was added, the page now displays 'Last Update Submitted that Met QC Criteria,' and headers include 'No FEAR Act Data' and 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check42 days agoChange DetectedMinor version update from v3.3.3 to v3.3.4; no study content or usability elements appear affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page shows a minor site update: Revision: v3.3.3 was added and Revision: v3.3.2 was removed, and the HHS Vulnerability Disclosure link was deleted. These changes pertain to footer/site versioning and do not alter core study content or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision label updated to v3.3.2, replacing the previous v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to CAN04 Combined with FOLFIRINOX in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAN04 Combined with FOLFIRINOX in Pancreatic Cancer Clinical Trial page.